BioAge Labs, Inc. (BIOA)
20.14
+0.54
(+2.78%)
USD |
NASDAQ |
Feb 19, 16:00
20.15
+0.02
(+0.07%)
After-Hours: 20:00
BioAge Labs Market Cap : 840.69M for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 965.17B |
| Plus Therapeutics, Inc. | 40.53M |
| BioStem Technologies, Inc. | 104.28M |
| Iovance Biotherapeutics, Inc. | 1.129B |
| Protokinetix, Inc. | 2.036M |
Market Cap Related Metrics
| PS Ratio | 121.99 |
| PEG Ratio | -5.068 |
| Price to Book Value | 3.030 |
| Price | 20.14 |
| Earnings Yield | -10.50% |
| PEGY Ratio | -5.068 |